Cell Biotech Dividends and Buybacks
Dividend criteria checks 3/6
Cell Biotech is a dividend paying company with a current yield of 3.14% that is well covered by earnings. Next payment date is on 3rd April, 2025 with an ex-dividend date of 27th December, 2024.
Key information
3.1%
Dividend yield
0%
Buyback Yield
| Total Shareholder Yield | 3.1% |
| Future Dividend Yield | n/a |
| Dividend Growth | 0.1% |
| Next dividend pay date | 03 Apr 25 |
| Ex dividend date | 27 Dec 24 |
| Dividend per share | ₩450.000 |
| Payout ratio | 28% |
Recent dividend and buyback updates
Recent updates
Shareholders Will Be Pleased With The Quality of Cell Biotech's (KOSDAQ:049960) Earnings
Aug 24
Factors Income Investors Should Consider Before Adding Cell Biotech Co., Ltd. (KOSDAQ:049960) To Their Portfolio
May 05Is Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Recent Price Movement Underpinned By Its Weak Fundamentals?
Mar 18A Look At Cell Biotech's (KOSDAQ:049960) Share Price Returns
Feb 25Key Things To Watch Out For If You Are After Cell Biotech Co., Ltd.'s (KOSDAQ:049960) 3.2% Dividend
Feb 04
Is Cell Biotech Co., Ltd. (KOSDAQ:049960) Popular Amongst Insiders?
Jan 14Don't Race Out To Buy Cell Biotech Co., Ltd. (KOSDAQ:049960) Just Because It's Going Ex-Dividend
Dec 24Cell Biotech Co., Ltd.'s (KOSDAQ:049960) Stock Is Rallying But Financials Look Ambiguous: Will The Momentum Continue?
Dec 13Reflecting on Cell Biotech's (KOSDAQ:049960) Share Price Returns Over The Last Five Years
Nov 18Stability and Growth of Payments
Fetching dividends data
Stable Dividend: A049960 has been paying a dividend for less than 10 years and during this time payments have been volatile.
Growing Dividend: A049960 has only been paying a dividend for 5 years, and since then payments have fallen.
Dividend Yield vs Market
| Cell Biotech Dividend Yield vs Market |
|---|
| Segment | Dividend Yield |
|---|---|
| Company (A049960) | 3.1% |
| Market Bottom 25% (KR) | 1.2% |
| Market Top 25% (KR) | 4.0% |
| Industry Average (Biotechs) | 0.6% |
| Analyst forecast (A049960) (up to 3 years) | n/a |
Notable Dividend: A049960's dividend (3.14%) is higher than the bottom 25% of dividend payers in the KR market (1.19%).
High Dividend: A049960's dividend (3.14%) is low compared to the top 25% of dividend payers in the KR market (3.98%).
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (28.1%), A049960's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (17%), A049960's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
Company Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/02/01 18:27 |
| End of Day Share Price | 2025/01/31 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Cell Biotech Co., Ltd. is covered by 9 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Young Ok Kim | DAOL Investment & Securities Co., Ltd. |
| Hyuk Jin Yoon | Eugene Investment & Securities Co Ltd. |
| Tae Hyun Kim | IBK Securities Co. Ltd. |